Adipokines and Nutritional Status for Patients on Maintenance Hemodialysis

Journal of Renal Nutrition

Volumn 20, Issue 5, 2010, Pages 303-308

  Malgorzewicz S ^a   Aleksandrowicz Wrona, E ^a   Owczarzak, A ^a   Debska Slizien A ^a   Rutkowski, B ^a   Lysiak Szydlowska W ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; LEPTIN; RESISTIN;

ARTICLE; BLOOD; BODY MASS; CHRONIC KIDNEY FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; MALNUTRITION; METHODOLOGY; MIDDLE AGED; NUTRITIONAL STATUS; OBESITY; RENAL REPLACEMENT THERAPY;

ADIPOKINES; ADIPONECTIN; BODY MASS INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; LEPTIN; MALE; MALNUTRITION; MIDDLE AGED; NUTRITIONAL STATUS; OVERWEIGHT; RENAL DIALYSIS; RESISTIN;

EID: 77955844663     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.10.005     Document Type: Article

References (30)

1. Kalantar-Zadeh K., Abbott K.C., Kronenberg F., et al. Epidemiology of dialysis patients and heart failure patients: special review article for the 25th anniversary of the Seminars in Nephrology. Semin Nephrol 2006, 26:118-133.
2. Beddhu S., Pappas L.M., Ramkumar N., et al. Effects of body size and body composition on survival in hemodialysis patients. J Am Soc Nephrol 2003, 14:2366-2372.
3. Nishizawa Y., Shoji T., Ishimura E. Body composition and cardiovascular risk in hemodialysis patients. J Ren Nutr 2006, 16:241-244.
4. Honda H., Quereshi A., Heimburger O., et al. Serum albumin, C-reactive protein, interleukin-6 and fetuin A as predictors of malnutrition, cardiovascular disease and mortality in patients with end-stage renal disease. Am J Kidney Dis 2005, 47:139-148.
5. Axelsson J. Obesity in chronic kidney disease: good or bad?. Blood Purif 2008, 26:23-29.
6. Enia G., Sicuso C., Alati G., et al. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 1993, 8:1094-1099.
7. Steiber A.L., Kalantar-Zadeh K., Secker D., et al. Subjective global assessment in chronic kidney disease: a review. J Ren Nutr 2004, 14:191-200.
8. Rutkowski B. 2007, Lublin, Leczenie Nerkozaste{ogonek}pcze. Czelej.
9. Engeli S., Feldpausch M., Gorzelniak K., et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003, 52:942-947.
10. Weikert C., Westphal S., Berger K., et al. Plasma resistin kevels and risk of myocardial infarction and ischemic stroke. J Clin Endocrinol Metab 2008, 93:2547-2553.
11. Pischon T., Girman C.J., Hotamisliqil G.S., et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004, 14:1430-1437.
12. Ayerden E.F., Ebinç H., Derici U., et al. The relationship between adiponectin levels and proinflammatory cytokines and left ventricular mass in dialysis patients. J Nephrol 2009, 22:216-223.
13. Guebe-Egziabher F., Bernhard J., Geelen G., et al. Leptin, adiponectin and ghrelin dysregulation in chronic kidney disease. J Ren Nutr 2005, 15:116-120.
14. Guebre-Egziabher F., Drai J., Fouque D. Adiponectin and chronic kidney disease. J Ren Nutr 2007, 17:9-12.
15. Wie{ogonek}cek A., Kokot F., Chudek J., et al. The adipose tissue: a novel endocrine organ of interest to the nephrologists. Nephrol Dial Transplant 2002, 17:191-195.
16. Chudek J., Adamczak M., Kania M., et al. Does plasma leptin concentration predict the nutritional status of hemodialyzed patients with chronic renal failure?. Med Sci Monit 9:CR377-CR382 2003.
17. Kwan B., Beddhu S. A story half untold: adiposity, adipokines and outcomes in dialysis population. Semin Dial 2007, 20:493-497.
18. Beige J., Heipmann K., Stumvoll M., et al. Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology. Exp Opin Ther Targets 2009, 13:163-173.
19. Scholze A., Tepel M. Role of leptin in reverse epidemiology in chronic kidney disease. Semin Dial 2007, 20:534-538.
20. Berg A., Combs T., Du X., et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001, 7:947-953.
21. Lindsay R.S., Funahashi T., Hanson R.L., et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002, 360:57-58.
22. Margetic S., Gazzola C., Pegg G., et al. Leptin: a review of its peripheral actions and interactions. Int J Obes 2002, 26:1-17.
23. Zoccali C., Mallamaci F., Tripepi G., et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002, 13:134-141.
24. Diez J., Iglesias P., Fernandez-Reyes M., et al. Serum concentration of leptin, adiponectin and resistin and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol 2005, 62:242-249.
25. Kato A., Odamaki M., Maruyama Y., et al. Association between circulating leptin and soluble receptors for tumor necrosis factor-alpha in hemodialysis patients. Clin Nephrol 2001, 56:370-377.
26. Carrero J., Aquilera A., Stenvinkel P., et al. Appetite disorders in uremia. J Ren Nutr 2008, 18:107-114.
27. Axelsson J., Heimburger O., Stanvinkel P. Adipose tissue and inflammation in chronic kidney disease. Contrib Nephrol 2006, 151:165-174.
28. Stenvinkel P., Marchlewska A., Pecoits-Filho R., et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004, 65:274-281.
29. Zanetti M., Barazzoni R., Guarinieri G. Inflammation and insulin resistance in uremia. J Ren Nutr 2008, 18:70-76.
30. Rasic-Milutinovic Z., Perunicic G., Pljesa S., et al. Metabolic syndrome in HD patients: association with body composition, nutritional status, inflammation and serum iron. Intern Med 2000, 46:945-951.